a manufacturer of products for breast cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with ABOS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then ABOS could also see price increases.
Ticker / NAME | Correlation To ATOS | 1D Price Change % | ||
---|---|---|---|---|
ATOS | 100% | N/A | ||
ABOS - ATOS | 40% Loosely correlated | +3.16% | ||
ABCL - ATOS | 37% Loosely correlated | -5.48% | ||
ALLO - ATOS | 37% Loosely correlated | -9.56% | ||
NTLA - ATOS | 35% Loosely correlated | -6.15% | ||
DNLI - ATOS | 34% Loosely correlated | -3.98% | ||
More |
Ticker / NAME | Correlation To ATOS | 1D Price Change % |
---|---|---|
ATOS | 100% | N/A |
cancer theme (82 stocks) | 37% Loosely correlated | -2.35% |
medical research theme (126 stocks) | 26% Poorly correlated | -1.85% |
medical service theme (154 stocks) | 25% Poorly correlated | -1.97% |